Table 2.

Unadjusted odds ratios (ORs) of COVID-19 among cancer patients compared to COVID-19 in the non-cancer population by tumor subtype and oncological treatment modality.

	Number of individuals with cancer and COVID-19	Number of individuals with cancer without COVID-19	Odds ratio of COVID-19 disease (95% CI)
All cancer C00-96 (ICD-10)	547	305299	1.15 (1.05–1.26)
Solid tumors (all except C81–96)	493	279686	1.13 (1.03–1.24)
Non-solid tumors C81–96	54	25613	1.35 (1.02–1.77)
Digestive organs C15–26	73	40671	1.15 (0.90–1.45)
Respiratory organs C30–34, C38	13	9986	0.84 (0.44–1.43)
Melanoma of the skin C43	65	27071	1.54 (1.19–1.97)
Skin, non-melanoma C44	33	14932	1.42 (0.98–2.00)
Breast C50	85	49738	1.10 (0.88–1.36)
Female genital organs C51–58	33	23827	0.87 (0.60–1.23)
Male genital organs C60–63	105	58874	1.16 (0.95–1.42)
Urinary organs C64–68	35	20852	1.08 (0.75–1.50)
Central nervous system C70–72	20	13685	0.94 (0.57–1.45)
Thyroid gland C73	20	5975	2.15 (1.31–3.32)
<1 year since cancer diagnosis	53	38806	0.88 (0.66–1.15)
1–5 years since cancer diagnosis	151	79152	1.22 (1.04–1.44)
≥5 years since cancer diagnosis	343	187341	1.18 (1.05–1.31)
Chemotherapy including targeted therapy and immunotherapy last 3 months	71	45599	1.00 (0.78–1.26)
Surgery last 3 months	90	44566	1.30 (1.04–1.60)
Stem cell or bone marrow transplant last 12 months	0	514	0.00 (0.00–4.80)
Radiotherapy last 3 months	7	4929	0.91 (0.37–1.88)

The number of individuals without cancer but with COVID-19 was 7 841 and the number of individuals without cancer and without COVID-19 was 5 034 186.